Ultrastructural and growth factor analysis of amniotic membrane preserved by different methods for ocular surgery;Análise ultraestrutural e de fatores de crescimento de diferentes métodos de preservação da membrana amniótica utilizada em cirurgia ocular

Arquivos Brasileiros de Oftalmologia

Volumn 70, Issue 5, 2007, Pages 756-762

  Pena, Janethe Deolinda de Oliveira ^a   de Melo, Gustavo Barreto ^a   Gomes, José Álvaro Pereira ^a   Haapalainen, Edna Freymuller ^a   Komagome, Ciro Massayuki ^a   Santos, Namir Clementino ^a   Filho, Acácio Alves de Souza Lima ^a   Rizzo, Luiz Vicente ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amnion; Cytokines; Dimethyl sulfoxide; Electron; Glycerol; Microscopy; Transforming growth factor beta

Indexed keywords

EID: 39049100121     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492007000500006     Document Type: Article

References (33)

1. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83(6):748-52.
2. Chen HJ, Pires RT, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol. 2000;84(8):826-33.
3. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49(1):51-77.
4. Meller D, Tseng SC. [Amniotic membrane transplantation with or without limbal allografts in corneal surface reconstruction in limbal deficiency]. Ophthalmology. 2000;97(2):100-7. German.
5. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997;104(6):974-85.
6. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82(3):235-40.
7. Gomes JAP, Fernandes LH, Komagome CM, Höfling-Lima. AL, Prata Junior JA. Uso de membrana amniótica no tratamento de complicaçōes pós-trabeculectomia. Arq Bras Oftalmol. 2001;64(5):437-41.
8. Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124(6):765-74.
9. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14 (5):473-84.
10. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, et al. Surgical reconstruction of the ocular surface in advancdd ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122(1):38-52.
11. Shimazaki J, Yang HY, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology. 1997;104(12):2068-76. Comment in: Ophthalmology. 2000; 107(3):411-2.
12. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998; 116(4):431-41.
13. Gruss JS, Jirsch DW. Human aminiotic membrane: a versatile wound dressing. Can Med Assoc J. 1978;118(10):1237-54.
14. Mathews RN, Faulk WP, Bennett JP. A review of the role of amniotic membranes in surgical practice. Obstet Gynecol Annu. 1982;11:31-58.
15. Colocho G, Graham WP, 3rd, Greene AE, Matheson DW, Lynch D. Human amniotic membrane as physiologic wound dressing. Arch Surg. 1974;109(3): 370-3.
16. Fujishima H, Shimazaki J, Shinozaki N, Tsubota K. Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma. Ophthalmic Surg Lasers. 1998;29(5):428-31.
17. Grant MB, Khaw PT, Schultz GS, Adams JL, Shimizu RW. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-ß on corneal cell chemotaxis. Invest Ophthalmol Vis Sci. 1992;33(12): 3292-301.
18. Wilson SE, Schultz GS, Chegini N, Weng J, He YG. Epidermal growth factor, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor and interleukin-1 proteins in the cornes. Exp Eye Res. 1994;59(1):63-72.
19. Koizumi N, Inatomi T, Sotozono C, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factors mRNA and protein in preserved amniotic membrane. Curr Eye Res. 2000;20(3):173-7.
20. Schilling B, Yeh J. Transforming growth factor-(1), -beta(2), -beta(3) and their type I and II receptors in human term placenta. Gynecol Obstat Invest. 2000;50(1):19-23.
21. Hao, Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000; 19(3):348-52.
22. Paradowska E, Blach-Olszewska Z, Gejdel E. Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta. 1997;18(5-6):441-6.
23. Fortunato SJ, Menon R, Swan KF, Lombardi SJ. Interleukin-10 inhibition of interleukin-6 in human amniochorion membrane: transcriptional regulation. Am J Obst Gynecol. 1996;175(4 Pt 1):1057-65.
24. Trautnum MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ. Expression of interleukin-10 in human gestacional tissues. J Soc Ginecol Investig. 1997;4(5):247-53.
25. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001; 20(4):408-13.
26. Kruse FE, Joussen AM, Rohrschneider K, You L, Sinn B, Baumann J, et al. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol. 2000;238(1):68-75.
27. Kubo M. Sonoda Y, Muramatsu R. Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci. 2001,42(7):1539-46.
28. von Versen-Hoynck F, Syring C, Bachmann S, Moller DE. The influence of different preservation and sterilisation steps on the histological properties of amnion allografts-light and scanning electron microscopic studies. Cell Tissue Bank. 2004;5(1):45-56.
29. Fujisato T, Tomihata K, Tabata Y, Iwamoto Y, Burczak K. Ikada Y. Cross-linking of amniotic membranes. J Biomater Sci Polym Ed. 1999;10(11):1171-81.
30. Maral T, Borman H, Arslan H, Demirhan B, Akinbingol G, Haberal M. Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing. Burns. 1999;25(7):625-35.
31. Marshall L, Ghosh MM, Boyce SG, MacNeil S, Freedlander E, Kudesia. G. Effects of glycerol on intracellular virus survival: implications for the clinical use of glycerol-preserved cedaver skin. Burns. 1995;21(5):356-61.
32. van Baare J, Ljgtvoet EEJ, Middelkoop E. Microbiological evaluation of glycerolized cadaveric donor skin. Transplantation; 1998;65(7):966-70.
33. van Baare J, Buitenwerf J, Hoekstra MJ, du Pont JS. Virucidal effect of glycerol as used in donor-skin preservation. Burns. 1994;20(Suppl 1):S77-80.